Physician profile

Anil Verma

Cardiovascular Disease · Cincinnati, OH

NPI 1669521365

$33,292.99

in general payments reported to CMS, 2019-2025

49 companies · $5,211 in 2025

The $5,211 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$11,822.89
Consulting Fee$1,000.00
Travel and Lodging$823.14

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $5,584.42 2019-2020
Boston Scientific Corporation $4,830.08 2019-2025 Watchman Access System, Watchman, Wolverine Coronary Cutting Balloon
Imperative Care, INC $4,498.42 2023-2025 Symphony Catheter, Prodigy Catheter, Zoom 88-T Large Distal Platform
Abbott Laboratories $4,287.08 2019-2025 Triclip, Xact, Mitraclip
Inari Medical, INC. $2,338.54 2020-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Abiomed $2,040.45 2019-2025 Impella
Edwards Lifesciences Corporation $1,351.65 2020-2025 Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Novartis Pharmaceuticals Corporation $1,262.50 2019-2025
Janssen Pharmaceuticals, INC $1,094.72 2019-2023 Xarelto
Ekos Corporation $1,018.87 2019
Shockwave Medical, INC $598.03 2021-2022
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $379.53 2019-2022
Esperion Therapeutics, INC. $354.95 2020-2023 Nexletol
Cardiovascular Systems INC. $314.80 2021-2022
Amgen INC. $308.08 2019-2022
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Livanova USA, INC. $287.44 2023 Lifesparc
Medtronic, INC. $275.93 2021-2022
Pfizer INC. $221.05 2019-2024
Angiodynamics, INC. $212.39 2020-2021
Avinger INC. $194.03 2019-2021
Boehringer Ingelheim Pharmaceuticals, INC. $153.73 2019-2023 Jardiance
Bard Peripheral Vascular, INC. $145.29 2021
Medtronic Vascular, INC. $144.11 2019
Biotronik INC. $142.46 2019
Sanofi-Aventis U.S. LLC $138.37 2019
Tactile Systems Technology INC $116.59 2021-2023 Entre Plus, Flexitouch Plus
Merck Sharp & Dohme LLC $115.73 2021-2022
Getinge USA Sales, LLC $100.22 2019
Bayer Healthcare Pharmaceuticals INC. $79.41 2021-2023
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $75.10 2019-2022
Bardy Diagnostics, INC. $65.00 2020
Truvic Medical, INC. $59.61 2022
Regeneron Healthcare Solutions, INC. $57.07 2019
Novo Nordisk INC $52.15 2019-2023 Ozempic
Astrazeneca Pharmaceuticals LP $45.93 2019-2021
Amarin Pharma, INC. $43.45 2020-2021
Actelion Pharmaceuticals US, INC. $38.21 2019-2022
Astellas Pharma US INC $37.48 2020-2021
Chiesi USA, INC. $36.95 2020-2021
Daiichi Sankyo INC. $32.00 2019
Stryker Corporation $28.04 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Kestra Medical Technology Services, INC. $24.08 2024 Assure Wcd
Terumo Medical Corporation $23.52 2019
E.R. Squibb & Sons, L.L.C. $23.14 2019
Surmodics, INC. $20.37 2024 Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System
Lundbeck LLC $15.75 2019
Thrombolex, INC. $12.21 2023
Gilead Sciences, INC. $11.07 2019
Cvrx, INC. $2.99 2025 Barostim Neo System

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Anil Verma

$33,292.99

in general payments reported 2019-2025

Years
2019-2025
Top company
Penumbra, INC.
Context
The $5,211 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/301981/anil-verma

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.